Inventor

STANTON MATTHEW G

US60 patents

⚠️ This page may combine multiple inventors who share the name “STANTON MATTHEW G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

STANTON MATTHEW G

SIRNA THERAPEUTICS INC

Diether based biodegradable cationic lipids for siRNA delivery

RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

Low molecular weight cationic lipids for oligonucleotide delivery

Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery

RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)

Low molecular weight cationic lipids for oligonucleotide delivery

RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA)

Low molecular weight cationic lipids for oligonucleotide delivery

Short interfering nucleic acid (siNA) molecules containing a 2′ internucleoside linkage

Diether based biodegradable cationic lipids for siRNA delivery

Low molecular weight cationic lipids for oligonucleotide delivery

Low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery

RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

Low molecular weight cationic lipids for oligonucleotide delivery

Cationic lipids with various head groups for oligonucleotide delivery

Low molecular weight cationic lipids for oligonucleotide delivery

Low molecular weight cationic lipids for oligonucleotide delivery

RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

Short interfering nucleic acid (siNA) molecules containing a 2′ internucleoside linkage (3dT)

Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery

Low molecular weight cationic lipids for oligonucleotide delivery

Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery

MERCK SHARP & DOHME

Spirocyclic compounds

Spirocyclic compounds

Histone deacetylase inhibitors with aryl-pyrazolyl-motifs

Benzothiophene derivatives

Dual molecular delivery of oligonucleotides and peptide containing conjugates

Dual molecular delivery of oligonucleotides and peptide containing conjugates

MERCK & CO INC

Spirocyclic compounds

Pyrazinone thrombin inhibitors

Thrombin inhibitors

Thrombin inhibitors

GENERATION BIO CO

Lipids and nanoparticle compositions thereof

Lipids and nanoparticle compositions thereof

Lipids and compositions thereof

COLLETTI STEVEN L

Low molecular weight cationic lipids for oligonucleotide delivery

Cationic lipids for oligonucleotide delivery

BUDZIK BRIAN W

Low molecular weight cationic lipids for oligonucleotide delivery

Amino alcohol cationic lipids for oligonucleotide delivery

STANTON MATTHEW G

Low molecular weight cationic lipids for oligonucleotide delivery

Low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery

HARRINGTON PAUL

4-carboxybenzylamino derivatives as histone deacetylase inhibitors

4-carboxybenzylamino derivatives as histone deacetylase inhibitors

CANCILLA MARK

RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

BROWN DUNCAN

RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)

HEIDEBRECHT JR RICHARD W

Pyridyl derivatives as histone deacetylase inhibitors

ALTMAN MICHAEL D

Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitors

GRIMM JONATHAN B

Inhibitors of histone deacetylase